We have made amazing progress in the treatment of COVID-19. Two therapies, in particular, have already been shown to help.
The plasma bank will be set up at the Delhi government-run Institute of Liver and Biliary Sciences. Kejriwal said his government will make transportation arrangements for those willing to donate their plasma.
As world waits for COVID-19 vaccine, India must use time to build robust immunisation plan, delivery system for last-mile reach
Right from selecting the strategy for delivery of COVID-19 vaccine to recruiting a large volunteer staff, every tool must be analysed from the perspective of India’s unique public health system and its capabilities
Glenmark claims that favipiravir showed improvement of up to 88 percent in mild to moderate COVID-19 cases.
Indian regulators give Glenmark approval to manufacture, sell favipiravir for ‘restricted emergency use’ in treating COVID-19 patients
Glenmark Pharmaceuticals Ltd has received Indian regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to-moderate COVID-19 infections in the country
US study claims low dose radiation therapy could help treat pneumonia in COVID-19 patients; results under peer review
Preliminary results of a US study showed that within 24 hours of receiving low-dose radiation therapy, four COVID-19 patients with pneumonia showed rapid improvement in their breathing
Coronavirus Outbreak: Antiviral drug Umifenovir to undergo clinical trial in CSIR institute, says health ministry
Union Health Minister Harsh Vardhan said that the drug Umifenovir prevents the entry of the COVID-19 into human cells and also acts by priming the immune system.
COVID-19 treatment: Study suggests cellular nanosponges could restrict SARS-CoV-2 virus multiplication; animal trials underway
Studies conducted by researchers at UC San Diego showed that cellular nanosponges could reduce the ability of SARS-CoV-2 virus that causes COVID-19 disease to infect host cells
Treating COVID-19: As widely-available steroid dexamethasone raises hopes, a look at other potential treatments in trials already
So far there are no approved treatments for the coronavirus infection which has claimed more than 443,000 lives globally and 9,900 in India alone
Steroids like dexamethasone can suppress immune systems, and many physicians are using them on a case-by-case basis.
COVID-19 'RECOVERY' Trial: Dexamethasone found life-saving in seriously-ill patients in preliminary tests
As part of the Recovery trial, a range of potential treatments is being tested in consenting COVID-19 patients admitted to NHS hospitals in the UK.
Generic steroid drug Dexamethasone reduces deaths among severely-ill COVID-19 patients, claim UK researchers
Researchers in the UK have said that a recent clinical trial has shown that a generic steroid drug, dexamethasone, can reduce deaths among COVID-19 patients on ventilator by one-third
As there is no specific treatment for COVID-19, antibiotics are being used inappropriately to treat symptoms in people confirmed or suspected with COVID-19, increasing the chance of them developing resistant to the antimicrobial treatments
More than 100 potential COVID-19 vaccines are in various stages of development around the world.
Tychan is said to begin human clinical trials next week for a potential monoclonal antibody treatment for the COVID-19 infection.
COVID-19 treatment: Scientists say brand new flu drug might help in reducing viral load, prevent SARS-CoV-2 transmission
Scientists believe a brand new influenza drug that can help in inhibiting COVID-19 virus replication, may help reduce the morbidity and mortality due to the novel coronavirus
A research team have isolated single-domain antibodies called VHHs from a llama affectionately known as Winter.
Stock Market Latest Updates: Sensex soars 997 points, Nifty holds 9,850-level; ONGC, HCL Tech among major gainers
Stock market today LIVE Update: Sensex above 33,000, Nifty surges past 9,800-mark; RIL, HUL share prices gain ahead of Q4 results
Shares of Strides Pharma Science Ltd on Wednesday zoomed 20 percent after the company said it has developed and commercialised Favipiravir antiviral tablets, and stressed that the drug has demonstrated positive outcomes in COVID-19 treatment globally
Coronavirus Global Roundup, April 24: The US records over 3,000 deaths in a day while China records none in a week
COVID-19 has now globally infected more than 2.75 million people and taken 192,000 lives.